Background. The 2009 pandemic influenza A (H1N1)(A [H1N1] pdm09) vaccine component
has remained unchanged from 2009. We estimate the effectiveness of current and prior …

Vaccines are a cost-effective and successful means for preventing disease. Routine health
vaccine administration begins in early childhood and extends into the elderly; however …

Questions have been recently raised regarding the safety of vaccine adjuvants, particularly
in relation to autoimmunity or autoimmune disease (s)/disorder (s)(AID). The International …

Approximately 70 years passed between the licensing of alum salts as vaccine adjuvants
and that of MF59™ MF59, an oil-in-water emulsion, is currently licensed for use in the …

Introduction: During the past century, vaccinologists have attempted to mimic pathogens in
their immune-enhancing capacity. This led to the development of life-saving vaccines based …

Introduction Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory
tract infections in infants. An investigational vaccine using an engineered recombinant RSV …

Many varieties of new, complex diseases are constantly being discovered, which leaves
scientists with little choice but to embrace innovative methods for controlling the invasion of …

Abstract Patients with Systemic Lupus Erythematosus (SLE) pose a unique dilemma
pertaining to immunization against common pathogens. SLE patients are usually not …

Despite the very low risk-to-benefit ratio of vaccines, fear of negative side effects has
discouraged many people from getting vaccinated, resulting in reemergence of previously …

To determine if newer influenza vaccines can safely improve seroprotection rates of older
adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized …